Goldman Sachs recently updated its long-term forecast to account for the S&P 500's historically expensive valuation and ...

An exchange-traded fund that equally weights stocks in the S&P 500 was climbing sharply Thursday, as most of the U.S. equity index’s sectors were up in afternoon trading. The Invesco S&P 500 Equal ...

Stephens analysts adjusted their stance on Paragon 28 , Inc. (NYSE:FNA), downgrading the stock from Overweight to Equal ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Barclays analyst Benjamin Theurer upgraded Gruma (GPAGF) to Overweight from Equal Weight. The firm told investors in a ...

Wells Fargo analyst Mohit Bansal downgraded Vertex Pharmaceuticals (VRTX) to Equal Weight from Overweight with an unchanged price target of $460. Published first on TheFly – the ultimate source ...

Wells Fargo analyst Colin Langan upgraded Dana (DAN) to Equal Weight from Underweight with a price target of $16, up from $10. The firm remains ...

Morgan Stanley downgraded Teradyne (TER) to Underweight from Equal Weight with a price target of $117, down from $121. Contrary to company and Street outlooks, the firm doesn’t expect Teradyne ...

Invest in SPDR S&P Biotech ETF (XBI) for long-term growth potential and diverse, equal-weighted portfolio in the biotech ...